The Top Ten Most Devastating Revelations Related to Pfizer’s mRNA COVID-19 Vaccine

The Pfizer COVID-19 ages 16+ vaccine clinical trial documents, which the pharmaceutical giant submitted to the Food and Drug Administration (FDA), are now publicly available online at https://icandecide.org/pfizer-documents/. Four years after the clinical trials began, the country and world still strive to understand what happened during the clinical trial, what will happen to those who took the shots, whether or not the “vaccine”-related harms can be addressed, and if similar drug rollouts and mandates can be prevented in the future. This is a distilled, yet comprehensive, look back at Pfizer’s clinical trial and the ten most devastating revelations so far about the Pfizer COVID “vaccine.” 

1. Contaminated “vaccine” with DNA plasmids and SV-40 genetic segments
2. Delayed and obscured death reports during Pfizer’s clinical trial
3. Miscarriages and reproductive impairments
4. Myocarditis and other cardiac adverse events 
5. Unblinding the placebo trial subjects almost 1.75 years early, sabotaging data
6. Bait and switch — Rolling out a minimally tested “vaccine” formula to the public instead of the main formula used in the trial
7. Debilitating and disabling adverse events
8. Bad batches of the “vaccine”
9. Vaccine-related “turbo cancers”
10. Use of risky lipid nanoparticles in the “vaccine” formula

#1  CONTAMINATED “Vaccine” with DNA Plasmids and SV-40 Genetic Segments

In late October 2023, news regarding Pfizer’s coronavirus vaccine circulated widely after Health Canada’s announcement about contamination of the vaccine. Health Canada, a governmental agency similar to the FDA, responded to inquiries prompted by findings from two esteemed scientists, Kevin McKernan and Phillip J. Buckhaults.  McKernan discovered extremely elevated levels of bacterial plasmid DNA in Pfizer’s COVID-19 vaccine, which Buckhaults subsequently validated. Health Canada confirmed that Pfizer had disclosed information about the DNA sequences during its submission.

The presence of DNA fragments in Pfizer’s “vaccine” is concerning because, if foreign DNA infiltrates into human cells, it can permanently alter human DNA and potentially lead to adverse events such as tumors and cancers. In addition, residual DNA may result in endotoxins being present in the vaccine, which can cause anaphylaxis or toxic shock.

During Pfizer’s clinical trial, involving over 46,000 subjects, the company used a manufacturing process referred to as ‘Process 1,’ a polymerase chain reaction (PCR) product generated RNA from an in vitro transcription process, to produce the BNT162b2 “vaccine.” PCR is  a technique to replicate segments of DNA. 

However, for mass production to be rolled out to the public, Pfizer employed a different manufacturing process from Process 1; its  ‘Process 2’ formula, utilizing an additional outside commercial plasmid that required DNA extraction, was tested on only about 250 subjects. 

Pfizer mentioned plasmids in its own documents, and the FDA made reference to evaluating Pfizer’s “residual DNA.” In Pfizer’s documentation submitted to the FDA’s Center for Biologic Evaluation and Research (CBER), it noted that a separate, outside document described the plasmid the company would use. One of Pfizer’s own online sources admitted to using plasmid DNA for mass production scaling up: “To produce the spike mRNA in the COVID-19 vaccine, plasmid DNA is utilized as a building block, or what is referred to as starting material. Non-infectious fractions of an SV40 sequence are present in the starting material used by Pfizer and BioNTech.” 

Pfizer used ‘Process 2’ to manufacture its COVID drug for public distribution and aimed to remove residual DNA fragments and inflammatory endotoxins. However, according to McKernan and Buckhaults, the cleanup process was inadequate. Referencing a May 2024 study, Kevin McKernan said, “We are no longer debating whether the shots are contaminated.” “We’re just debating whether they are 10-fold or 100-fold over the limit and how much they vary from lot to lot.” Another study reports finding up 500 times the permissible level of DNA impurities in Pfizer’s Comirnaty. As Pfizer’s emergency use authorized COVID-19 vaccine (BNT162b2) and Comirnaty, the fully approved FDA version, have the same ingredients but are “legally distinct,” it follows that many in the U.S. may have taken shots tainted with excessive DNA.

The FDA and Word Health Organization (WHO) state that residual DNA in a single vaccine dose should not surpass 10 nanograms (ng), one billionth of a gram. Pfizer claims the residual DNA in its vaccine is within standard regulatory guidance and that there are no cancer-causing genes (i.e., oncogenes) in its starting material. However, scientists found billions to hundreds of billions of DNA molecules per dose of Pfizer’s vaccine, exceeding the FDA and WHO guidelines. A comparability study of Pfizer’s Process 1 and Process 2 formulas – both tested in their clinical trials – should have been conducted, but Pfizer never conducted one. From the Pfizer documents, analysts have determined that the clinical trial subjects who took the Process 2 formula suffered 2.4 times more adverse events than the placebo participants. The ratio of adverse events suffered by Process 2-vaccinated persons suggests that the contamination of the Process 2 formula caused more harm than the Process 1 formula.

The SV-40 segment. Pfizer also failed to disclose to the Canadian agency that the vaccine also contained a Simian Virus 40 (SV-40) sequence, an enhancer. The SV-40 protomer sequence has potential to turn on gene expression, including cancer-causing genes. In the 1960s, the whole SV-40 sequence was found in polio vaccines, and it caused a wave of cancers. Thus, learning of the presence of the SV-40 sequence in the Pfizer COVID vaccine alarmed millions worldwide who had already taken it. Multiple independent laboratories have since corroborated the contamination findings. 

There is a “significant excess risk of SV40 associated with human primary brain cancers, primary bone cancers, malignant mesothelioma, and non-Hodgkin’s lymphoma.”, Using a “small piece of [SV-40] DNA” has been utilized in vaccine manufacturing for decades as an enhancer to facilitate DNA transcription, the process of copying DNA information onto an mRNA molecule. 

Manufacturing Facilities & Adverse Events. The contamination data raised questions about what standard FDA inspections of Pfizer’s manufacturing facilities revealed. In response to a FOIA request and related lawsuit, the FDA withheld some 16,000-plus pages of documentation, based upon the statutory exemption for trade secrets, that is assumed by the attorneys receiving the produced documents to be quality control documentation. That quality control data could shed light on how contamination occurred and what needed to be corrected in the process to completely filter out the DNA plasmids. 

Many very serious diagnoses are listed on Pfizer’s own post-marketing report released 90 days after its COVID-19 vaccine hit the market in the United Kingdom and should have precipitated the withdrawal of Pfizer’s vaccine from the market. The Surgeon General of Florida, Dr. Joseph Ladapo, is one voice who has sought an end to the use of COVID mRNA vaccines due to the DNA and SV-40 enhancer/promoter, but he has not yet been successful. Remedial paths are available for correcting challenges with problematic drugs. Drugs can and have been pulled from the market before, and pharmaceutical companies have entered into large settlement agreements in the past., 

#2   Pfizer OBSCURED Reports of DEATHS during its Clinical Trials

In its clinical trial, Pfizer reported deaths in Case Report Forms (CRFs), which contain detailed individual subjects’ medical narratives. Pfizer failed to include all clinical trial deaths in the data it submitted to the FDA when seeking emergency use authorization. Pfizer knew several deaths had occurred prior to the EUA submission data cut-off date but did not enter that death information into the subjects’ CRFs until after the data cut-off date, thus ensuring they did not get submitted to the FDA.

The FDA decided the Pfizer vaccine met the required evidence of effectiveness on the comparison of COVID disease symptoms among the vaccinated compared to the placebo group. After observing participants for a week after a two-dose vaccine series, eight people in the vaccinated group had COVID, and 162 in the placebo group had COVID. 

When the FDA reviewed Pfizer’s data, the agency saw death data as of November 14, 2020, included six clinical trial deaths – four in the placebo arm, and two in the vaccine arm. Although Pfizer was obligated to report all deaths promptly, it delayed reporting some deaths. Pfizer’s protocol and FDA regulations called for reporting clinical trial deaths as soon as possible but no later than 15 days after death. Pfizer knew about additional deaths before the EUA data cut-off date, by 26 days and 37 days respectively. A peer-reviewed study shows that, in fact, more vaccine recipients than placebo subjects died prior to the granting of the EUA on December 11, 2020. With the incomplete data, the FDA had a basis for saying that the vaccine prevented COVID-19 [and deaths] more effectively than did a placebo. Dr. Jeyanthi Kunadhasan, one of the DailyClout Pfizer document analysts, and an author on the peer-reviewed published article, condensed the crucial Pfizer omission of deaths in a seven-minute educational video report. There, the data are broken down, showing 11 deaths occurred before the data cut-off date, six in the vaccinated group, and five in the placebo group. 

Missed Cardiac Signal. Pfizer’s delayed death reports caused another problem. Moderna’s then ongoing clinical trial had enough incidences of cardiac arrest to be labeled a ‘signal,’ i.e., a suspected adverse event related to its vaccine. All of Pfizer’s clinical trial deaths included cardiac issues. Had the correct Pfizer data, revealing its cardiac signal, been submitted to the FDA, the agency may have been more alert to Moderna’s cardiac adverse events. 

The prestigious New England Journal of Medicine (NEJM) erroneously published, “Two BNT162b2 recipients died (one from arteriosclerosis, one from cardiac arrest), as did four placebo recipients.” Pfizer never corrected that statement, despite its knowledge that at least six additional clinical trial vaccine recipients died prior to the granting of EUA. Even more critically, the NEJM article was subsequently cited over 9,000 times, aiding the spread of inaccurate safety information among heath care practitioners.  This false information gave medical practitioners unfounded confidence in the safety of the Pfizer vaccine, and they probably encouraged patients to take it. 

In the 90 days following the beginning of public vaccination, Pfizer received reports of 1,223 people who died after receiving its COVID-19 shot. By October 2022, the number of Pfizer doses administered in the U.S. was over 375 million (375,644,351), including single doses and the two-dose regimen. Thus, a significant segment of the 333 million American population received Pfizer’s shots. A large percentage of them may be included in the excess death data identified by Edward Dowd.

A former Wall Street analyst, Mr. Dowd is the author of Cause Unknown: The Epidemic of Sudden Deaths in 2021 and 2022. Dowd calculated excess deaths after mass COVID vaccinations in the U.S. For ages 25 to 64, Dowd found a 23% excess mortality rate for the combined years of 2021 and 2022. That translated to the excess deaths of an estimated 300,000 individuals in that age group and time period. In the European Union (EU), by April 2023, a cumulative number of 8,368 people had died following Pfizer vaccination, an increase over the prior year’s 1,023 deaths. Even with such shocking information, the Centers for Disease Control and Prevention (CDC), in 2024, continues to recommend mRNA COVID-19 vaccines for all age groups.

# 3 Post-Pfizer “Vaccine” Miscarriages and Reproductive Impairments Increased

Pfizer’s partner, BioNTech completed a fertility and developmental study using 44 vaccinated Wistar Han rats and their offspring, which were euthanized, and fetuses were examined. Half of the pregnant rodents delivered naturally, and the offspring were observed for 21 days – a time frame that is too-short to detect many developmental issues, safety concerns, or fertility findings. 

The whole study was completed quickly, in only 42 days. It seems that a key purpose was to enable Pfizer to later mention this study in a fact sheet for vaccination providers. On page 35 of its fact sheet for vaccinators, Pfizer acknowledged that it did not have sufficient data on human pregnant subjects to be able to inform women on vaccination-associated risks in pregnancy. Thus, the fact sheet referred to the rat study stating the rats received the same dose as humans were then being given without any observed adverse effects.   

Pregnant women were excluded as subjects in the clinical trial, and all participants were advised to use two forms of birth control during the trial. In spite of Pfizer’s efforts to keep pregnant women out of the clinical trial, in its post-marketing report, there had been 270 unique mother pregnancy cases and four foetus/baby cases in its study, per Table 6, labeled “Description of Missing Information.” Of the pregnant women, 238 cases were listed as “no outcome provided;” 23 as spontaneous abortions (i.e., miscarriages); and two additional spontaneous abortions, one with neonatal death and one with intrauterine death. That means at least 25 post-vaccination miscarriages occurred.

In Pfizer’s request for emergency use authorization (EUA), it did not supply any pregnant women data but pledged to conduct safety and observation/evaluation studies after EUA approval. In February 2021, Pfizer began preparing the study, intending to include 4,000 subjects. However, Pfizer only recruited 349. Pregnant women were already taking the vaccine, and the CDC endorsed the vaccine for pregnant women in April 2021; therefore, Pfizer halted its pregnancy vaccine study. 

By July 2021, Pfizer sought a Biologics License Application (BLA) with updated data. The data is apparently cumulative, from December 2020 through July 2021. Fourteen pregnant women were hospitalized, and five suffered the deaths of their babies. There were 205 pregnant subjects with outcomes reported only as “resolve/resolving,” another 64 recorded as “not resolved,” four more with “resolved with sequelae,” and a shocking 849 noted as simply “unknown/no data.” Pfizer’s pregnant women data is set out in an ambiguous manner, which could be read as lacking information on more than 1,000 pregnant women. 

The VAERS data on pregnant women who suffered miscarriages after taking the Pfizer COVID vaccine were somewhat sparse in 2022. One of the most striking revelations derived was that among all of pregnant women who suffered miscarriages from December 2020 through March 2022, who also received a COVID vaccine, about 75% of them (2,557/3,414) had taken a Pfizer vaccine. Among vaccine-related miscarriages over the prior 30-year period, a remarkable 76% of them happened to women who had received a COVID-19 vaccine.

Among 567 cases of Pfizer post-vaccine miscarriages from December 2020 through December 2021, 96 spontaneous abortions (37.1% of cases) occurred in less than 24 hours after taking the vaccine. Six particular lots of Pfizer’s vaccine showed a significantly higher miscarriage rates among those 567 cases. Those six batches accounted for 13.3% of the total number of Pfizer vaccine-related miscarriages reported in this time frame. 

In December of 2022, U.S. Senator Ron Johnson held a public roundtable for scientists and medical experts to make brief presentations on the COVID-19 vaccines. Dr. James Thorp, an OB/GYN specialist with over 40 years’ experience, commented that in his practice, after patients’ mRNA vaccinations, he witnessed a substantial increase in menstrual abnormalities, infertility, miscarriage, fetal death, and fetal malformations. Consistent with his comment is 2021 data from the Department of Defense indicating that congenital malformations increased dramatically after COVID vaccines were mandated in the Armed Forces. The rate of congenital malformations had been relatively steady from 2016 through 2020. In 2020, the number was 10,153, but in 2021 it shot up to a shocking 18,951. 

In a February 2024 video interview, Dr. Kimberly Biss, an experienced OBGYN physician who collected and analyzed data from her own practice, reported that, after the mRNA injection rollout, miscarriages tripled. 

Data from Canada’s nationalized medical insurance system for pre-COVID Ontario (2015-2020) was compared to Ontario COVID vaccination years’ data (2021-2022). In a data set of approximately six million unique patients, the increased impairments to men and women’s reproductive systems were reportedly “catastrophic.” The Ontario data show that there were 540 more medical complaints of inflamed fallopian tubes, ovaries, and pelvic inflammatory in the first two years of COVID vaccination than during the dataset’s pre-vaccination years. Menstruation disorders increased by nearly 10,000 after the COVID-19 shots became publicly available. After the mRNA shots, menopause/post-menopausal bleeding increased by more than 22,000 cases; spontaneous and incomplete abortions together increased in Ontario by 5,397 after mRNA injections; and infertility among men and women went from the pre-publicly available COVID vaccination number of 94,039 up to 112,450 after it became available – a marked increase of 18,411. 

#4 Reports Linked Pfizer’s “Vaccine” to Myocarditis and other Cardiac issues. 

Myocarditis may be the most well-known adverse event from the Pfizer vaccine. This medical condition is an inflammation around the heart, a serious adverse event (SAE), that can “[weaken] the heart so that the rest of the body doesn’t get enough blood. Clots can form in the heart, leading to a stroke or heart attack.”  

Chronology of Pfizer’s Reports.  When Pfizer sought the EUA approval, the FDA assessed its data on November 20, 2020, and noted that, in the vaccinated group, there was only a 0.02% higher number of the serious adverse event acute myocardial infarction. The other SAEs were generally spread evenly between the vaccinated and placebo groups, “including no imbalance overall in cardiovascular serious adverse events.” Approximately 90 days later, Pfizer reported 1,403 cases of “cardiovascular events” in its cumulative analysis of post-EUA adverse events with breakout subcategory numbers of: tachycardia, 1,098; arrhythmia, 102; myocardial infarction, 89; cardiac failure, 80; acute myocardial infarction, 41; cardiac failure acute, 11; cardiogenic shock and postural orthostatic tachycardia syndrome (POTS), 7 each; and coronary artery disease, 6. Finally, by July 2021, Pfizer submitted its pharmacovigilance plan for a biologics license. In it, the company reported 490 myocarditis-related cases and 371 pericarditis-related events, among which there were three deaths, 213 “resolved/resolving” cases, 63 “not resolved” cases, seven “resolved with sequalae,” and 86 “unknown/no data”. 

In 2021, worldwide reports about people dying suddenly became commonplace, especially among young, male athletes. Cases of myocarditis continued to arise, although not directly linked to the sudden deaths, and the public learned Pfizer had listed myocarditis and pericarditis on its July 2021 Pharmacovigilance plan. These factors may have spurred Pfizer to conduct an internal inquiry about the concerning incidences of myocarditis and pericarditis., 

Pfizer’s February 11, 2022, investigatory report on myocarditis and pericarditis of vaccinated persons concluded that the reason(s) for these conditions, rising since April 2021 and primarily among males under age 29, “remain unknown.” Pfizer quietly kept its report on myocarditis and pericarditis in-house, labeling it “confidential” until journalistic organization, Project Veritas published it in March 2023. 

As a contrast, it is worthwhile to note that, before the pandemic, myocarditis was quite uncommon — 0.05% in pediatric admissions; worldwide 10.2 to 105.6 per 100,000 population; nine in 100,000 developed the condition without COVID-19; Defense Department rates were .00216%. Scientists noticed the elevated rates of myocarditis after Pfizer vaccination even before Pfizer’s in-house study became publicly available. A 2022 literature review of 39 studies, including 129 Pfizer-vaccinated patients, showed that 64 were diagnosed with myocarditis, 7.8% required intensive care unit hospitalization, and 1.6% died. 

Early Signal of link to Myocarditis.  The link between myocarditis and the Pfizer vaccine was identified soon after public vaccinations began. On February 28, 2021, less than three months after the EUA was granted in the United States, the Israeli Ministry of Health notified the CDC of a spike in myocarditis among vaccinated subjects. A follow-up report indicated a causal relationship to the COVID vaccine, particularly following the second vaccine dose. From December 2020 until May 2021, in Israel countrywide, there were 275 cases of myocarditis, 148 were closely related in time to a Pfizer vaccination. Twenty-seven myocarditis adverse events were reported shortly after the first dose. Within 30 days of the second Pfizer dose, that increased to 121 myocarditis cases Most involved males under age 30.

In Pfizer’s own February 2021 post-EUA analysis of adverse events, of the 1,346 cardiac events, 1,078, or 77%, of them occurred in non-elderly adults. Most commonly, these events manifested within 24 hours of receiving the Pfizer vaccine;136 events were fatal, which is an unusually high rate according to the DailyClout researchers. 

Interestingly, Pfizer’s post-marketing report categorized myocarditis  or pericarditis as “Immune Mediated/Autoimmune” adverse events instead of as cardiac adverse events. The myocarditis and pericarditis data appear on page 20 of Pfizer’s post-marketing report and show 57 instances of myocarditis or pericarditis out of 158,893 total adverse event reports among 42,086 cases. These incidences onset within seven days, most often within two days, which strongly suggests a correlation to the vaccine. 

Indeed, Pfizer seems to have hidden its knowledge of the myocarditis-vaccine correlation, as it did with death reports prior to obtaining the EUA. An analysis in WarRoom/DailyClout Report 84 shows, “…[there was an] over 3.7-fold increase in number of deaths due to cardiovascular events in vaccinated subjects compared to placebo subjects” prior to the granting of the EUA. 

As early as May 2021, the WHO acknowledged an mRNA COVID vaccine association with myocarditis and pericarditis. The pertinent CDC committee evaluated this but concluded the benefit of the vaccines outweighed the risks of these conditions. The FDA and the European Medical Agency (EMA) updated the Pfizer and Moderna vaccines’ product information. The advisory response recommended monitoring mRNA vaccine recipients, especially young men, and seeking medical attention when symptoms arose such as chest pain, shortness of breath, fatigue. A February 2024 CDC study concluded that Pfizer’s COVID vaccines resulted in higher risks of developing myocarditis (after first dose, 2.78 times the normal risk; after second dose, 2.86 times the normal risk; after third dose, 2.09 times the normal risk).

Another adverse event from Pfizer’s COVID vaccine is arrhythmia — i.e., an irregular heartbeat that can lead to stroke, heart attack, or heart muscle failure. A 2023 meta-analysis noted that among Pfizer, CoronaVac, and AstraZeneca vaccine recipients, Pfizer vaccinated persons exhibited the highest rate of arrhythmia, 95.47 per million compared to the others, 51.76 and 26.92, respectively. The analysis also found that the Pfizer vaccine was associated with 60.7% of the instances of new-onset arrhythmia (emphasis added). 

WarRoom/DailyClout researchers reviewed Pfizer’s post-marketing report on adverse events and noticed missing temperature data, which may indicate misdiagnoses of arrhythmia as tachycardia. WarRoom/DailyClout Report 35 discusses how categorizing heart-related symptoms as tachycardia could disguise cases of arrhythmia and in numbers more than seven times what Pfizer reported: 

Another interesting inclusion is the case of “Tachycardia” (1,098 cases). Tachycardia means elevated heart rate. Heart rates go up roughly 10 beats per minute for each degree of temperature gain. Strangely, there were 7,666 cases of Pyrexia (fever) using Celsius degrees that eliminated all temperature elevations between 99.6- and 100.3-degrees Fahrenheit. The under-reporting of fevers makes this reporting questionable. Were these “Tachycardias” cases actually cases of erratic heartbeat (Arrhythmia) that affect the heart’s upper chambers? The matter can only be resolved with raw data access that has not been provided.

# 5  Pfizer Unblinded the Placebo Group, Sabotaging Data.

 During Pfizer’s clinical trials for the COVID vaccine, it unblinded the control group at week 20 of Phase 3 of the trial. Unblinding means the participants of the control placebo group, who did not know whether they were receiving the vaccine or the placebo, learned they had received the placebo. At the point of unblinding, approximately 20,000 trial subjects had received placebo injections. Pfizer offered those trial subjects the opportunity to receive the COVID vaccine; and, within about three months, 19,696 of them received the Pfizer vaccine. Thus, nearly 90% of the trial’s control group chose to get vaccinated. The Pfizer clinical trial control group had been destroyed.

Pfizer’s vaccinating the placebo group began immediately after it obtained EUA and was complete by mid-March 2021. After placebo group subjects received the vaccine, they were no longer unvaccinated and, therefore, no long-term analytical, including safety, comparisons between vaccinated and unvaccinated subjects could be made. By July 2021, Pfizer’s updated report “attempted to substitute titer-based lab tests for efficacy, [blood tests in place of PCR tests] but later admitted lab titers do not represent disease protection.”

In 2020, PCR tests were already known to produce false negatives and positives for active COVID infections, and these were used in arriving to identify the eight vaccinated and 162 unvaccinated COVID cases which were the premise for granting EUA. By December 2021, the CDC withdrew its PCR COVID test as it could not distinguish between the flu and COVID-19. This casts further doubt on the trustworthiness of Pfizer’s “successful” data. 

In September 2023, a group of UK doctors and other specialists saw that Pfizer and others had been “eager to inject the placebo group.” The specialists opined that the pharmaceutical companies’ suspected goal was to deliberately eliminate the ability for anyone to conduct a properly controlled quantitative safety analysis.

# 6  Pfizer’s Bait and Switch – Manufacturing an Under-Tested “Vaccine” Formula

‘Bait and Switch’ is a term that arose out of the advertising business. It refers to an underhanded sales tactic of announcing to customers an inexpensive product to draw them into a place of retail sales. The tactic continues when the business then informs the customer that the item is unavailable, on back order, or sold out and attempts to persuade the customer to buy a similar item at a higher price. The practice is regarded as fraudulent and deceptive. During Pfizer’s COVID vaccine clinical trials, it was already preparing a pharmaceutical manufacturing switch for when it obtained emergency use authorization from the FDA.

In October 2020, Pfizer started a new mini trial, referred to as “Process 2”, in the midst of its then ongoing main clinical trial. It comingled the Process 2 data with the main “Process 1” study data, though the manufacturing processes for the two were very different. Pfizer made only a cursory note about it in an October 2020 protocol amendment submitted to the FDA. Pfizer’s final protocol, dated April 15, 2020, noted that “Process 2 was developed to support increased scale of manufacture.” Further into the Protocol document, Pfizer stated that the manufacturing would involve changes in the method of production, namely, “…using material from lots generated using the manufacturing process supporting increased supply. . . for production of the DNA template . . . and the RNA drug substance purification method.” The public was not informed of a this significant change to the manufacturing process of the vaccines that would be rolled out to the public until a court-ordered release of the Pfizer documents began. 

The ‘Process 2’ formula was later determined to be contaminated. Pfizer used that second formula for its mass vaccine distribution. Research scientist, Kevin McKernan, who, with colleagues, found DNA and SV40 fragments in Pfizer’s vaccine in 2023, said that Pfizer had performed a “bait and switch.” The company had changed to a different manufacturing method when it scaled up or began mass production. Internally, Pfizer’s clinical study protocol from April 2020 planned this alternate manufacturing process, referring to it only briefly, “. . .  ‘Process 2’ was developed to support an increased scale of manufacture.” By October 2022, Pfizer’s contaminated Process 2 vaccine had been widely distributed, and more than 375,644,351 doses had been injected into the arms of Americans. 

The Process 2 mini trial consisted of 502 individuals with vaccination and placebo control groups. Of the Process 2 mini trial participants, 252 received the vaccine, and they suffered 2.4 times more adverse events than the ‘Process 1’ vaccinated group. The revelation of the Process 2 formula and contamination sparked increased interest about Pfizer’s manufacturing processes. As already noted, the FDA has declined to disclose information about Pfizer’s quality control efforts, explaining that Pfizer asserts its related data as protected trade secret data under the Freedom of Information Act (FOIA). Pfizer intended to mass produce only the minimally tested COVID vaccine formula.

# 7  Pfizer Vaccine Recipients Suffered Debilitating and Disabling Adverse Events

The CDC and Pfizer use the CIOMS VI definition of “adverse events of special interest” (AESI), which is, “An adverse event of special interest is one of scientific or medical concern specific to the sponsor’s product or programme, for which ongoing monitoring and rapid communication by the investigator to the sponsor could be appropriate. Such an event might require further investigation in order to characterise and understand it. Depending on the nature of the event, rapid communication by the trial sponsor to other parties (e.g., regulators) might be warranted.”

In its post-marketing report to the FDA, 90 days after the initial rollout of the Pfizer vaccine for public vaccination, Pfizer reported a massive list of 1290 AESIs in an over eight-page, single-spaced ‘Appendix 1.’  The information in Appendix 1 was not released to the public until a court ordered the FDA to release the Pfizer clinical trial documents.

Vast array of injuries. The adverse events of special interest impacted entire body systems — neurological, cardiovascular, musculoskeletal, reproductive, multi-organs, etc. Just a small list of some medical conditions reported after vaccination with  Pfizer’s novel gene therapy drug include: anaphylaxis, arthritis, chronic fatigue syndrome, autoimmune disorders, Guillain-Barré syndrome, seizures, multiple sclerosis, meningitis, herpes, acute respiratory distress syndrome, thromboembolic events, and strokes. A 2024 CDC study of COVID vaccine adverse events, including from Pfizer’s vaccine, derived information from approximately one million medical records in eight countries. The effort turned up evidence of increased safety signals — i.e., adverse events significantly higher than anticipated for myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis, as well as a potential signal for ADEM, acute disseminated encephalomyelitis, an autoimmune disease that involves serious brain and spinal cord inflammation.

Rising Death Rates.  The many serious adverse events from the Pfizer vaccine (and others) may be related to the profound events since public vaccinations. Sudden deaths have risen dramatically, especially in the young and among athletes. Between 2021 and 2022 alone, more than 1,650 athletes collapsed due to cardiac events, and 1,148 of them died. While their vaccination statuses remain largely unknown, it is well-known that many high school and, especially, college and professional sports’ players were required to take COVID vaccines. Knowing that Pfizer was the first and largest provider of COVID vaccines, at least in the U.S., some significant portion of those vaccinees surely took Pfizer’s vaccine.

In 2023, the CDC acknowledged an unusually high mortality rates among 15- to 45-year-olds, over a 20% increase compared to insurance industry historical norms.

In November 2023, a senior military medical Services Corps officer posted a short video reviewing Defense Department data on fixed-wing and helicopter pilots. This whistleblower claimed that the data showed a 937% increase in heart failure, a 152% increase in cardiomyopathy, a 69% increase in ischemic heart disease, a 62% increase in pulmonary heart disease, a 36% increase in hypertensive disease, and a 63% increase in other forms of heart disease compared to the five-year average before 2022.

From January 2021 to December 2023 there have been large decreases in employment in hospitality, food services, retail, financial activities, professional services, and durable goods manufacturing. The “quit” rate ranges from (1.4% to 4.1%) and in one sector it reached over 6%. The job decreases may well be due in part to COVID vaccine disabilities. Author and statistical researcher, Edward Dowd, noted a 55% increase in employment disability claims among women in data from the bureau of Labor Statistics. 

# 8  Reports Indicate Pfizer Distributed Bad Batches of its Vaccine. 

The high incidence of sudden deaths due to cardiac events after receiving a Pfizer COVID vaccine has been demonstrated. The inexplicable information on so-called “hot lots,” and the associated high death and adverse event numbers, found in the Vaccine Adverse Events Reporting Systems (VAERS) database is similarly disturbing.

The Informed Consent Action Network (ICAN) obtained COVID vaccine lot data from Pfizer and Moderna and matched it to VAERS and OpenVAERS. ICAN analyzed the data, which seems to indicate that particular lots corresponded with a “unusually high” number of adverse reactions. ICAN prepared an example bar chart of twenty lots of Pfizer and Moderna incidences of myocarditis per million doses of each company’s vaccine, side by side. It is a visually striking image, showing that both companies’ products appear to have extremely similar profiles of myocarditis diagnoses. Viewing the charts from the bottom up, both companies’ products showed an increasing number of myocarditis-associated cases from slightly less than 10 per million, up to Pfizer’s 95 cases per million and Moderna’s approximately 45 cases per million. 

Dr. Michael Yeadon, a former Pfizer Vice President, explained that vaccine lots should contain uniform ingredients, so adverse events and deaths that occur should have a similar frequency across lot numbers.  The footnoted article contains an itemized VAERS list from 2021 and early 2022 with 104 purported “hot lots.” A second column itemizes the number of VAERS’ reported deaths associated with each lot number. The number of deaths per lot runs from single digits to a high of 117. Although Dr. Yeadon has been criticized as an anti-vaxxer, he had no influence on the VAERS data. In fact, the data appears to be the same set of numbers discussed earlier in a 2021 article by Karl Denninger, who was commenting on an article in Exposé. 

Dr. Yeadon has not been the only source to reference an uneven distribution of fatalities or adverse events among Pfizer vaccine lots. DailyClout highlighted six Pfizer vaccine batches, or lot numbers, associated with 13.8% of miscarriages after vaccination, which was derived from the https://wonder.cdc.gov/ website on May 2, 2022. The same WarRoom/DailyClout Report 28 charted 65 Pfizer batch/lot numbers identified as dangerous to the health of the patient. The chart presented each batch/lot number and its corresponding adverse reactions (ADRs), deaths, disabilities, and life-threatening illnesses.

General concerns of bad batches among the Pfizer and other companies’ lots gave rise to making VAERS batch data accessible on a website. Using VAERS data in 2021, researcher Craig Paardekooper created an accessible database, How Bad Is My Batch?, as a public service Paardekooper has maintained an extensive and detailed database financed by donations and containing data from Pfizer and other vaccine manufacturers. He made the data searchable from numerous angles. For example, one database is subtitled, “International Deadly Lots,” which includes data on Pfizer, Moderna, and Janssen vaccines. It lists lot numbers and the associated number of adverse reports, deaths, disabilities, life-threatening reactions, and percentages of reports within the lot that are severe. However, the pharmaceutical company name is not listed, so site visitors can only check using a known lot number of a pharmaceutical company. As of this writing in January 2024, that site has been visited nearly 179 million times since June 2023.

Anecdotal problems with Pfizer Batches/Lots.  In Europe, Pfizer submitted a period safety update report (PSUR) covering the period from December 19, 2020, to June 18, 2021. On pages 56 and 57 of the report, Pfizer identified 21 batches of “the most frequently reported lot numbers,” associated with a high number of adverse events. The number of adverse events ranged from a low of 2,133 in a single batch to the high of 16,077 — in one batch! The report did not correlate the specific adverse events with batch or lot numbers. The data referred to BNT162b, which was identified on page 2 and in a footnote as “Comirnaty,” The FDA-approved version of Pfizer’s COVID vaccine. Paradoxically, immediately after the graph list, Pfizer wrote, “Overall, there were no related quality issues identified during investigations of these lot/batch numbers.”

In Denmark, concerns were raised about 52 Pfizer batches which seemed to result in significantly more side effects. A question was submitted to the European Parliament on October 5, 2023. The parliamentary question may have been raised in relation to an unexpected finding that in Denmark batches, SAEs per 1,000 doses varied considerably between batches, both in rates and seriousness. The authors of that 2023 study concluded there was a batch-dependent safety signal for Pfizer’s BNT162b2 vaccine which warranted further investigation. 

In 2021, a cache of leaked documents from the European Medical Agency (EMA) revealed that regulators had strong concern about the unexpectedly low quantities of mRNA in Pfizer vaccine batches. 

In Japan, in September 2021, five vials of Pfizer vaccine from the same lot contained foreign matter visible to the naked eye. Three cities put aside the vials and requested testing from Pfizer. 

A Pfizer whistleblower leaked an internal email from January 2021 to Pfizer employees at a New York research site explaining that workers would be provided with a special batch of COVID vaccines that were “separate and distinct” from those provided to governments and the general public. During an Australian senate hearing in 2023, a Pfizer representative conceded that the company had imported a batch of vaccine specifically for its employee vaccination program. This action is generally consistent with Pfizer knowingly providing different batches to different populations. 

#9 Vaccine-Related “Turbo Cancers” 

One of the most alarming developments in the wake of the COVID vaccines is the onset of fast-growing cancers, particularly among people in their 20s and 30s, which have been dubbed “turbo cancers.” This is a phenomenon previously unknown to medicine. Advanced cancers (stages 3 and 4) are typically diagnosed as soon as the patient notices any symptoms. In December 2023, CDC acknowledged this trend, noting a monstrous 143,233% increase in fatal cancers following COVID vaccinations. Canadian oncologist Dr. William Makis has seen a lot of the fast-growing turbo cancers, occurring mostly in people vaccinated with the Pfizer or Moderna vaccines. These turbo cancers are resistant to the usual cancer treatments, and the patients may only survive for weeks or months but not for more than a year. On his Substack, Dr. Makis incorporated U.K. data on deaths and cancer diagnoses analyzed by author Edward Dowd. The data show shocking increases in deaths from cancers from 2020 to 2022, primarily in the 15- to 44-year-old range.

A United Kingdom report shows that “turbo cancers” – including breast, colon, brain, nonspecific neoplasms, and skin cancers – have risen very sharply since the public began receiving COVID vaccines. Ibid Dr. Makis supplemented his Substack posting with another article, “New Report: Young People Dying of Cancer at ‘Explosive’ Rates, UK Government Data Show” by Mike Capuzzo, which also discussed Edward Dowd’s findings. The temporal relationship between the public introduction of COVID vaccines and the dramatic rise in cancers causes one to deduce that a significant portion of the 2022 cancer deaths very well may be attributable to the contaminated COVID vaccines.

Additionally, David Wiseman, one of the authors of “DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events,” commented that the FDA’s insistence that there is no evidence of a link between the mRNA COVID vaccines and cancer is becoming “untenable.” Dr. Buckhaults’ comment that Pfizer’s contaminated vaccine involved either “malice or incompetence” may have proven to be prophetic.

Chris Woollums, a UK researcher and leading writer on cancer, wrote recently on his Cancer Active blog that Pfizer vaccines are triggering changes and damages to the immune system, making people vulnerable to cancers. He raised the question whether turbo cancer is the new pandemic. He commented that the CEO of Pfizer likely thinks so, noting the company’s recent acquisition of pharmaceutical company Seagen, which specializes in cancer drugs, and another pharmaceutical company, Arena Pharmaceuticals, which makes cardiovascular drugs.

By April 2024, Dr. Peter McCullough outlined three possible ways that COVID-19 vaccines could start cancers or promote already existing cancers in the body. McCullough calls this the “multi-hit hypothesis of oncogenesis after COVID-19 vaccination.” First, messenger RNA that is in mRNA vaccines (Pfizer, Moderna, etc.) can impair the body’s own function of DNA repair. Second, the spike protein in the vaccine, according to a University of Pittsburgh study, appears to inhibit the body’s natural p53 and BRCA tumor suppression systems. Finally, McCullough notes that four labs have found elevated levels of DNA process-related impurities in Pfizer and Moderna vaccines. The vaccines have SV-40 genetic segments and antibiotic resistance fragments present in the vaccines and have turbo cancer-causing potential.

The American Cancer Society has predicted that cancer rates will rise by 77% by the year 2050. The World Health Organization (WHO) said this increase will result in 35 million new cancers, and the number of deaths could run over 18 million.

There are increasing reports of association of cancer to the mRNA vaccines. In April 2024, Japan declared an emergency over an explosion of mRNA-related cancers. Statistically significant increases in aggressive forms of cancer occurred in the country from 2020 through 2022, the time frame in which mRNA vaccines were introduced. Six new COVID-19 vaccine turbo cancer papers have been published in April 2024 and allege Pfizer and Moderna vaccines cause cancer. (The studies  review: N1-methyl-pseudouridine in relation to cancer; death after 3rd mRNA lipid nanoparticle dose in Japan; an Adenoid Cystic Carcinoma with BNT162b2 Vaccine immune response; and intertwined cases of B-cell lymphoma and a leukaemia[sic] and lymphoma.) Japan’s most senior cancer doctor, Dr. Masanori Fukushima, has declared that COVID shots are “essentially murder” and has called for the World Health Organization to investigate the COVID vaccine harms. A new study indicates Pfizer’s mRNA “triggered” a rare blood cancer, angioimmunoblastic lymphoma. 

April 2024 VAERS data analyzed by Ed Dowd shows that multiple-cause cancer deaths in 2022 exceeded the period from 2010 to 2019 trend by a staggering 16%. Between 2010 and 2020 cancer rates had gone down, then began to climb back up in 2020 for the 75 to 84 age group. For that age group, there were about 47,000 multiple-cause excess cancer deaths and underlying-cancer deaths in 2022. After 2020, Dowd explained, a drop in excess cancer mortalities was expected to correspond to the probable deaths of cancer patients who were sick during the pandemic. Instead, excess cancer deaths in 2021 surpassed 2020, and those from 2022 surpassed 2021 in a continuous upward trend. Ed Dowd’s cancer death data was taken for the U.S.’ Vaccine Adverse Event Reporting System, so the connection between the COVID vaccines and the 2021 and 2022 cancers upward trend seems clear. In short, new cancers rose dramatically after mass inoculation of the population with COVID-19 vaccinations. The COVID-19 shots likely contributed to excess deaths from underlying-cancers and multiple-cause cancers in 2021 and 2022. 

# 10 Pfizer’s Chose to Use Risky Lipid Nanoparticles

A key feature of Pfizer’s vaccine was the use of lipid nanoparticles (LNPs). The LNPs are microscopic fat bubbles which hold inside them the famed coronavirus spike proteins. Some in the science community touted LNPs as so promising and revolutionary that they had the potential to change the course of history. Within 90 days of mass COVID vaccination in the U.S., Pfizer became aware of so many “adverse events of special interest” that it filled nine single-spaced pages itemizing them.

The LNP substance is made of a material with a charge that attracts to and penetrates into human cells. Once inside the cells, the vaccine ingredients trigger the body to begin manufacturing spike proteins, and then the body creates antibodies to fight the SARS-CoV-2. Some LNPs may not penetrate cells, and those circulate throughout the bloodstream. 

History of risks.  LNPs had a known unfavorable history in human pharmaceutical research. The record of LNPs had been long known as high-risk to human health. Research and development with LNPs centered on an innovative methodology to deliver therapeutics into cells to treat cancers. However, studies clearly showed that using LNPs for humans was contraindicated and ill-advised due to the health dangers. Specifically, LNPs have been strongly associated with inflammation, autoimmune reactions, myocarditis and other cardiac conditions, blood clotting, neurological problems, and cancer. In mice studies, LNPs caused inflammation, even killing 80% within a 24-hour period. There are no long-term studies on LNPs, but inflammation has been a known concern with them. LNPs, and they can affect the vagus nerve, which helps regulate functions like breathing, digestion, heart rate, blood pressure, respiration, and reflex actions (coughing, sneezing, swallowing, etc.)

A 2018 report noted that there had been substantial attention paid to nanoparticles and their possible toxic effects on the liver, brain, kidney, and reproductive organs.

What Pfizer Knew; What Vaccinations Revealed.  There is currently no known means of removing LNPs (and their harmful cargo) from the human body. Pfizer told the public that the vaccine would remain in the deltoid muscle of the arm, but it knew from its own 2020 biodistribution study using luminescent markers, that the LNPs migrated throughout the body.

Pfizer’s LNPs were made of polyethylene glycol (PEG), a petroleum derivative. Some people have allergies to PEG, which can cause a health emergency, such as anaphylaxis, cardiac arrest, which can lead to death., People without specific PEG allergies can still suffer pseudo-allergic reactions.

Pathologist Dr. Ryan Cole explained that the mRNA vaccines cause large, unusually firm, non-dissolvable blood clots. While direct causation has not been established, there appears to be a very strong association between blood clotting and deaths following COVID shots. Since 2021, reports from embalmers in the U.S., U.K., and Australia have noted discoveries and extractions of long, stringy, light-colored clots from deceased persons. These types of clots had not been observed prior to the COVID vaccinations. The clots are fibrous, rubbery, and interfere with the ability to infuse embalming fluid into bodies. Thus, the clots had to be removed.

The Pfizer LNP and spike protein design turns human cells into spike protein producing factories. As one author put it, “[t]here is an uninvestigated and major concern that the mRNA could transform body cells into viral protein factories — with no off-switch — that produce the spike protein for a prolonged period causing chronic systemic inflammation and immune dysfunction.” In short, the LNPs, in conjunction with the spike protein, seem to be functioning as biologic runaway trains of immune responses, resulting in truly dangerous health risks. 

PDF Essay Containing Endnotes

Please Support DailyClout!

Pre-Order The Pfizer Papers Book.

Become a DailyClout Member.